Author + information
- Received December 10, 2007
- Revision received February 14, 2008
- Accepted March 5, 2008
- Published online July 1, 2008.
- Takashi Kubo, MD, PhD,
- Toshio Imanishi, MD, PhD,
- Hironori Kitabata, MD,
- Akio Kuroi, MD,
- Satoshi Ueno, MD,
- Takashi Yamano, MD,
- Takashi Tanimoto, MD,
- Yoshiki Matsuo, MD, PhD,
- Takashi Masho, MD,
- Shigeho Takarada, MD, PhD,
- Atsushi Tanaka, MD, PhD,
- Nobuo Nakamura, MD,
- Masato Mizukoshi, MD, PhD,
- Yoshiaki Tomobuchi, MD, PhD and
- Takashi Akasaka, MD, PhD⁎ ()
Reprint requests and correspondence:
Dr. Takashi Akasaka, Department of Cardiovascular Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama, 641-8509, Japan.
Objectives The aim of the present study was to compare lesion morphologies after sirolimus-eluting stent (SES) implantation between patients with unstable angina pectoris (UAP) and stable angina pectoris (SAP) with the use of optical coherence tomography (OCT).
Background The lesion morphologies before and after coronary stenting have been proposed as important predictors of clinical outcome. The high resolution of OCT provides detailed information of coronary vessel wall.
Methods We enrolled 55 patients (UAP: n = 24, SAP: n = 31), and examined lesion morphologies by using OCT at pre- and post-SES implantation and 9 months' follow-up.
Results The incidence of plaque rupture (42% vs. 3%, p < 0.001), intracoronary thrombus (67% vs. 3%, p ≤ 0.001) and thin-capped fibroatheroma (cap thickness <65 μm; 46% vs. 3%, p < 0.001) at pre-intervention was significantly greater in UAP than that in SAP. Although stent profiles and procedural characteristics were not different between the 2 groups, inadequate stent apposition (67% vs. 32%, p = 0.038) and tissue protrusion (79% vs. 42%, p = 0.005) after percutaneous coronary intervention were observed more frequently in patients with UAP. Plaque rupture was significantly increased after percutaneous coronary intervention in patients with UAP (42% to 75%, p = 0.018), and the persistence of core cavity after plaque rupture (28% vs. 4%, p = 0.031) at 9 months' follow-up was observed more frequently in UAP patients compared with SAP patients. At 9 months' follow-up, the incidence of inadequately apposed stent (33% vs. 4%, p = 0.012) and partially uncovered stent by neointima (72% vs. 37%, p = 0.019) was significantly greater in UAP patients than that in SAP patients. All patients took aspirin and ticlopidine during follow-up period, and no patients had stent thrombosis or adverse coronary events.
Conclusions Serial OCT examinations demonstrated markedly different vascular response up to 9 months after SES implantation between UAP and SAP patients. Although the inadequate lesion morphologies after stenting were observed more frequently in UAP patients, these findings were not associated with adverse outcomes in patients with antiplatelet therapy.
- Received December 10, 2007.
- Revision received February 14, 2008.
- Accepted March 5, 2008.
- American College of Cardiology Foundation